Safety, Tolerability, and Efficacy of MK-7655 (Relebactam) + Imipenem/Cilastatin Versus Imipenem/Cilastatin Alone for Treating Complicated Urinary Tract Infection (cUTI) (MK-7655-003)
Clinical trial NCT01505634 · COMPLETED
Trial details
- NCT number
- NCT01505634
- Sponsor
- Merck Sharp & Dohme LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2012-05-16
- Primary completion
- 2015-07-28
- Enrollment
- 302
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.